{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:18:43Z","timestamp":1761844723246},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T00:00:00Z","timestamp":1486166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1093\/jac\/dkw583","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T20:07:40Z","timestamp":1482350860000},"page":"1450-1455","source":"Crossref","is-referenced-by-count":15,"title":["Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa"],"prefix":"10.1093","volume":"72","author":[{"given":"Ruth L.","family":"Goodall","sequence":"first","affiliation":[{"name":"MRC CTU at UCL, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Dunn","sequence":"additional","affiliation":[{"name":"MRC CTU at UCL, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Nkurunziza","sequence":"additional","affiliation":[{"name":"MRC\/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lincoln","family":"Mugarura","sequence":"additional","affiliation":[{"name":"Joint Clinical Research Centre, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Pattery","sequence":"additional","affiliation":[{"name":"Janssen Diagnostics, a division of Janssen Pharmaceuticals NV, Beerse, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Munderi","sequence":"additional","affiliation":[{"name":"Joint Clinical Research Centre, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cissy","family":"Kityo","sequence":"additional","affiliation":[{"name":"Joint Clinical Research Centre, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Gilks","sequence":"additional","affiliation":[{"name":"School of Population Health, University of Queensland, Brisbane, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pontiano","family":"Kaleebu","sequence":"additional","affiliation":[{"name":"Joint Clinical Research Centre, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deenan","family":"Pillay","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute, KwaZulu Natal, South Africa"},{"name":"Division of Infection and Immunity, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra K.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute, KwaZulu Natal, South Africa"},{"name":"Division of Infection and Immunity, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the DART Virology Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,4]]},"reference":[{"key":"key\n\t\t\t\t20180328172037_dkw583-B1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.1230413","article-title":"Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment","volume":"339","author":"Bor","year":"2013","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B2","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.1228160","article-title":"High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa","volume":"339","author":"Tanser","year":"2013","journal-title":"Science"},{"author":"WHO","key":"key\n\t\t\t\t20180328172037_dkw583-B3"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1473-3099(09)70136-7","article-title":"Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis","volume":"9","author":"Gupta","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B5","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1086\/648444","article-title":"Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa","volume":"49","author":"Hoffmann","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B6","doi-asserted-by":"crossref","first-page":"20798.","DOI":"10.7448\/IAS.19.1.20798","article-title":"Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya","volume":"19","author":"Brooks","year":"2016","journal-title":"J Int AIDS Soc"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B7","doi-asserted-by":"crossref","first-page":"e0145536.","DOI":"10.1371\/journal.pone.0145536","article-title":"Virological response and antiretroviral drug resistance emerging during antiretroviral therapy at three treatment centers in Uganda","volume":"10","author":"Kaleebu","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study","volume":"16","author":"TenoRes Study G","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B9","article-title":"Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study","author":"Gregson","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B10","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/infdis\/jit107","article-title":"Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings","volume":"207","author":"Hosseinipour","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B11","first-page":"132","article-title":"Update of the drug resistance mutations in HIV-1","volume":"23","author":"Wensing","year":"2015","journal-title":"Topics Antiviral Med"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/648590","article-title":"Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus nevirapine and zidovudine-lamivudine plus abacavir","volume":"201","author":"Ndembi","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/AAC.38.1.23","article-title":"Recombinant virus assay: a rapid, phenotypic assay for assessment of drug susceptibility of human immunodeficiency virus type 1 isolates","volume":"38","author":"Kellam","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.42.2.269","article-title":"A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs","volume":"42","author":"Hertogs","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B15","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1128\/AAC.01197-10","article-title":"Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1","volume":"55","author":"McCormick","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B16","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1371\/journal.pmed.0040335","article-title":"N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance","volume":"4","author":"Yap","year":"2007","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/aid.2011.0136","article-title":"Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa","volume":"28","author":"Sigaloff","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B18","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/INF.0b013e3181e47609","article-title":"Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine","volume":"29","author":"Gupta","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B19","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1093\/infdis\/jit112","article-title":"Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy\u2013implications for sustained efficacy of art in resource-limited settings","volume":"207","author":"Hill","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1086\/590943","article-title":"Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials","volume":"47","author":"Gupta","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B21","doi-asserted-by":"crossref","first-page":"e50307","DOI":"10.1371\/journal.pone.0050307","article-title":"Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens","volume":"7","author":"Scherrer","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis","volume":"380","author":"Gupta","year":"2012","journal-title":"Lancet"},{"author":"WHO","key":"key\n\t\t\t\t20180328172037_dkw583-B23"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/hiv.12303","article-title":"Safety of zidovudine dose reduction in treatment-naive HIV infected patients. A randomized controlled study (MiniZID)","volume":"17","author":"Rougemont","year":"2016","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJMoa1311274","article-title":"Assessment of second-line antiretroviral regimens for HIV therapy in Africa","volume":"371","author":"Paton","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/infdis\/jis261","article-title":"Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in sub-Saharan Africa","volume":"205","author":"Sigaloff","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1473-3099(11)70255-9","article-title":"Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study","volume":"12","author":"Hamers","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","author":"Wittkop","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B29","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/QAD.0b013e3283543e2c","article-title":"Viral load monitoring in resource-limited settings: a medical and public health priority","volume":"26","author":"Ford","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328172037_dkw583-B30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/QAI.0b013e318227fc34","article-title":"Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa","volume":"58","author":"Sigaloff","year":"2011","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/5\/1450\/13703458\/dkw583.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T04:38:31Z","timestamp":1601267911000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/72\/5\/1450\/2970124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,4]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,2,4]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw583","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published-other":{"date-parts":[[2017,5]]},"published":{"date-parts":[[2017,2,4]]}}}